Perceived Barriers to Colorectal Cancer Screening among Physicians Who Routinely Recommend Screening in Tertiary Hospitals in Jos, Plateau State, Nigeria
Main Article Content
Abstract
Background: Colorectal cancer (CRC) is a leading cause of cancer related mortality worldwide. Increased incidence and mortality are projected in low-and-middle-income countries (LMICs) in the near future. Screening is suboptimal in LMICs and hindered by a multifactorial combination of barriers. This study assessed physicians perceived barriers to CRC screening on the provider, patient and system levels.
Methods: This cross-sectional study was conducted among physicians who routinely screen patients for CRC in two tertiary hospitals in Plateau state, Nigeria. The study assessed provider, patient and system-related barriers to CRC screening from providers’ perspectives. Seventy-three physicians were selected using a multi-stage sampling technique. Data was collected using a semi-structured self-administered questionnaire.
Results: A lack of knowledge of screening (63%) and lack of training to carry out screening tests (61.6%) were considered major physician-related barriers. Surveyed physicians identified a high number of patient-related factors such as financial constraints (86.3%), lack of insurance cover (75.3), low literacy (75.3%) and limited access to screening (71.2%) as major barriers. Most of the system-related barriers in the questionnaire were considered major barriers to screening including high screening costs (71.2%), lack of resources for screening (71.2%), long waits for GI endoscopy (68.5%), a shortage of trained doctors (60%) and lack of hospital screening policy (68.5%).
Conclusions: Systemic barriers were the most identified barriers in this study, a pattern commonly seen in LMICs. Patient related barriers which are commonly associated with lower socioeconomic groups were also perceived to play a more prominent role than provider related barriers.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The Journal is owned, published and copyrighted by the Nigerian Medical Association, River state Branch. The copyright of papers published are vested in the journal and the publisher. In line with our open access policy and the Creative Commons Attribution License policy authors are allowed to share their work with an acknowledgement of the work's authorship and initial publication in this journal.
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author.
The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations. While the advice and information in this journal are believed to be true and accurate on the date of its going to press, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.
TNHJ also supports open access archiving of articles published in the journal after three months of publication. Authors are permitted and encouraged to post their work online (e.g, in institutional repositories or on their website) within the stated period, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). All requests for permission for open access archiving outside this period should be sent to the editor via email to editor@tnhjph.com.
How to Cite
References
1. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soertjomatarm I, Jemal A et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–63.
2. Wong MC, Huang J, Lok V, Wang J, Fung F, Ding H et al. Differences in incidence and mortality trends of colorectal cancer worldwide based on sex age and anatomic location. Clin Gastroenterol Hepatol. 2021;19(5):955-66
3. Arnold M, Sierra MS, Laversanne M, Seorjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683-91
4. Bishehsari F, Mahdavinia M, Vacca M, Malekzadeh R, Mariani-Costantini R. Epidemiological transition of colorectal cancer in developing countries: environmental factors, molecular pathways, and opportunities for prevention. World J Gastroenterol. 2014;20(20):6055.
5. Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol. 2021 Oct 1;14(10):101174.
6. Agyemang-Yeboah F, Yorke J, Obirikorang C, Batu EN, Acheampong E, Frempong EA, et al. Patterns and presentations of colorectal cancer at Komfo-Anokye teaching hospital Kumasi, Ghana. Pan Afr Med J. 2017;28(1):142
7. Irabor D, Adedeji OA. Colorectal cancer in Nigeria: 40 years on. A review. Eur J Cancer Care. 2009;18(2):110–115.
8. Missaoui N, Jaidaine L, Abdelkader AB, Trabelsi A, Mokni M, Hmissa S. Colorectal cancer in Central Tunisia: increasing incidence trends over a 15-year period. Asian Pac J Cancer Prev. 2011;12(4): 1073–1076.
9. Ibrahim KO, Anjorin AS, Afolayan AE, Badmos KB. Morphology of colorectal carcinoma among Nigerians: A 30‑year review. Niger J Clin Pract. 2011; 14:432‑5.
10. Center MM, Jemal A, Ward E. International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomark and Prev. 2009;18(6):1688-94.
11. Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, Mortality, Survival and risk factors. Gastroenterology review/przeglad Gastroentorologiczny. 2019;14(2):89-103.
12. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30
13. Issa IA, Noureddine M. Colorectal cancer screening: An updated review of the available options. World J Gastroenterol. 2017;23(28):5086.
14. Onyekwere CA, Ogbera AO, Abdulkareem FB, Ashindoitiang J. Colorectal carcinoma screening in Lagos, Nigeria. Are we doing it right? Gastroenterology Res. 2009;2(2):38.
15. Lussiez A, Dualeh SH, Dally CK, Opoku BK, Raghavendran K, Aitpillah F et al. Colorectal cancer screening in Ghana: Physicians practices and perceived barriers. World J Surg. 2021;45(2):390-403.
16. Adonis L, Basu D, Luiz J. Predictors of adherence to screening guidelines for chronic diseases of lifestyle, cancers, and HIV in a health-insured population in South Africa. Glob Health Action. 2014;7(1):23807.
17. Brown T, Lee JY, Park J, Nelson CA, McBurnie MA, Liss DT. Colorectal cancer screening at community health centers: A survey of clinicians' attitudes, practices, and perceived barriers. Prev Med Rep. 2015; 2:886-91.
18. Lee R, Holmes D. Barriers and recommendations for colorectal cancer screening in Africa. Glob Health Action. 2023;16(1):2181920.
19. Ray-Offor E, Abdulkareem FB. Screening colonoscopy in Port Harcourt, Nigeria. Gastroenterol Insights. 2019;10(1):7987
20. Al-Azri M, Al-Khatri L, Panchatcharam SM. Attitudes toward and knowledge of colorectal cancer screening among an Omani adult population attending a teaching hospital. Asian Pac J Cancer Prev. 2020;21(10):3061.
21. Unger-saldana K, Saldana-Tellez M, Potter MB, Van Loon K, Allen-leigh B, Lajous M. Barriers and facilitators for colorectal cancer screening in a low-income urban community in Mexico City. Implement Sci Commun. 2020;1(1):1-5.
22. Hernandez-leal MJ, Perez-Lacasta MJ, Feijoo-Cid M, Ramos-Garcia V, Carles-Lavila M. Healthcare professionals’ behaviour regarding the implementation of shared decision making in screening programmes: A systematic review. Patient Educ Couns. 2021;104(8):1933-44.
23. Wang H, Roy S, Kim J, Farazi PA, Siahpush M, Su D. Barriers of colorectal cancer screening in rural USA: a systematic review. Rural Remote Health. 2019;19(3):1-0.
24. Weiss JM, Pickhardt PJ, Schumacher JR, Potvien A, Kim DH, Pfau PR et al. Primary care provider perceptions of colorectal cancer screening barriers: implications for designing quality improvement interventions. Gastroent Res Pract. 2017;2017(1):1619747.
25. Zhu X, Weiser E, Jacobson DJ, Griffin JM, Limburg PJ, Rutten LJ. Provider-perceived barriers to patient adherence to colorectal cancer screening. Prev Med Rep. 2022; 25:101681.
26. Brand Bateman L, Khamess S, Abdelmoneim SE, Arafat W, Fouad MN, Khamis Y, et al. Designing an effective colorectal cancer screening program in Egypt: a qualitative study of perceptions of Egyptian primary care physicians and specialists. Oncology. 2020;25(10):e1525–31.
27. Lussiez A, Dally CK, Boateng EA, Bosompem K, Peprah E, Hayward L, et al. Barriers to colorectal cancer screening in Ghana: a qualitative study of patients and physicians. Cancer Causes Control. 2022;33(7):951–58.
28. Selmouni F, Amrani L, Sauvaget C, Bakkar M, El Khannoussi B, Souadka A, et al. Delivering colorectal cancer screening integrated with primary health care services in Morocco: lessons learned from a demonstration project. Cancer. 2022;128(6):1219–29.
29. Muthukrishnan M, Arnold LD, James AS. Patients' self-reported barriers to colon cancer screening in federally qualified health center settings. Prev Med Rep. 2019; 15:100896.
30. Parker RK, Ranketi SS, McNelly C, Ongondi M, Topazian HM, Dawsey SM, et al. Colorectal cancer is increasing in rural Kenya: challenges and perspectives. Gastrointest Endosc. 2019;89(6):1234–7.
31. Plateau State Government of Nigeria. Plateau |state, Nigeria| Britannica. www.britannica.com [internet]. [cited 2025 Apr 4]; Available from: https://www.britannica.com/place/Plateau-state-Nigeria.
32. Plateau (State, Nigeria)-Population Statistics, Charts, Map and Location [Internet]. [cited 2025 Apr 4]. Available from: https://citypopulation.de/en/Nigeria/admin/NGA032_plateau/.
33. Thanapirom K, Treeprasertsuk S, Rerknimitr R. Awareness of colorectal cancer screening in primary care physicians. J Med Assoc Thai. 2012 ;95(7):859-65
34. Oche MO, Adamu H. Determinants of patient waiting time in the general outpatient department of a tertiary health institution in Northwestern Nigeria. Ann Med Sci Res 2013; 3:588-92.
35. Willcox ML, Peersman W, Daou P, Diakité C, Bajunirwe F, Mubangizi V et al. Human resources for primary health care in sub-Saharan Africa: progress or stagnation? Hum Resour Health. 2015; 13:1-1.
36. May FP, Anandasabapathy S. Colon cancer in Africa: primetime for screening? Gastrointest Endosc. 2019;89(6):1238–40.
37. Amat M, Duralde E, Masutani R, Glassman R, Shen C, Graham KL. “Patient lost to follow-up”: opportunities and challenges in delivering primary care in academic medical centers. J Gen Intern Med. 2022;37(11):2678-83.
38. Gutusa F, Roets L. Early cervical cancer screening: The influence of culture and religion. Afr J Prim Health Care Fam Med. 2023;15(1):3776.
39. Elewonibi B, BeLue R. The influence of socio-cultural factors on breast cancer screening behaviors in Lagos, Nigeria. Eth Health. 2019;24(5):544-59.